美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Hemab Therapeutics Holdings, Inc.

39.40

-0.4800-1.20%

盤後：39.400.00000.00%19:04 EDT

成交量：40.81萬

成交額：1,624.46萬

市值：18.40億

市盈率：-22.11

高：42.48

開：40.26

低：38.98

收：39.88

52周最高：55.42

52周最低：23.00

股本：4,670.54萬

流通股本：1,675.00萬

量比：1.14

換手率：2.44%

股息：- -

股息率：- -

每股收益(TTM):-1.7820

每股收益(LYR):-67.5613

淨資產收益率：-46.99%

總資產收益率：-30.11%

市淨率：4.05

市盈率(LYR):-0.58

資料載入中...

總覽公司新聞公告

公司資料

公司名字：

Hemab Therapeutics Holdings, Inc.

交易所：

NASDAQ

成立時間：

2020

員工人數：

- -

公司地址：

101 Main Street,Suite 1220,Cambridge,Massachusetts,United States

官網：

http://www.hemab.com

郵編：

02142

電話：

傳真：

- -

簡介：

Hemab Therapeutics Holdings, Inc.於2026年2月12日根據特拉華州法律註冊成立。Hemab Therapeutics是一家臨床階段的生物技術公司，致力於開發革新血液凝固障礙治療的療法，以幫助維持生命並增強人類的抵抗力。公司的使命是通過發現、開發和商業化創新療法，為全球患有嚴重出血和血栓性疾病的患者打造領先的凝血領域公司。這些疾病包括格氏血小板無力症、VII因子缺乏症、血管性血友病以及其他可能造成終身沉重負擔的異常出血性疾病。公司的主要候選藥物sutacimig (HMB-001) 是一種雙特異性抗體，目前正在進行一項針對格氏血小板無力症預防性治療的I/II期臨床試驗和一項針對VII因子缺乏症預防性治療的II期臨床試驗。

董事

名稱

職位

Benny Sorensen

Chief Executive Officer and Director and President

Akshay Vaishnaw

Independent Director

ジョンマラガノア

Chair of the Board and Independent Director

Laura Tadvalkar

Independent Director

Linda Bain

Independent Director

股東

名稱

職位

Benny Sorensen

Chief Executive Officer and Director and President

Ananthram Murthy

Chief Operating Officer

Mads Behrndt

Chief Financial Officer and General Manager

Catherine Madigan

Chief Medical Officer

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/hant/stock/COAG/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"COAG","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"COAG\",,,,,undefined,":{"symbol":"COAG","market":"US","secType":"STK","nameCN":"Hemab Therapeutics Holdings, Inc.","latestPrice":39.4,"timestamp":1789156800000,"preClose":39.88,"halted":0,"volume":408085,"hourTrading":{"tag":"盘后","latestPrice":39.4,"preClose":39.4,"latestTime":"19:04 EDT","volume":30,"amount":1182.69,"timestamp":1789167844018,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.012036108324975025,"floatShares":16750000,"shares":46705400,"eps":-1.782,"marketStatus":"休市中","change":-0.48,"latestTime":"09-11 16:00:00 EDT","open":40.26,"high":42.4843,"low":38.98,"amount":16244562.05885,"amplitude":0.087871,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-1.782,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":7,"adr":0,"listingDate":1777608000000,"exchange":"NASDAQ","adjPreClose":39.88,"preHourTrading":{"tag":"盘前","latestPrice":40.44,"preClose":39.88,"latestTime":"09:29 EDT","volume":266,"amount":10645.0008,"timestamp":1789133399039,"change":0.56,"changeRate":0.014042,"amplitude":0.016299},"postHourTrading":{"tag":"盘后","latestPrice":39.4,"preClose":39.4,"latestTime":"19:04 EDT","volume":30,"amount":1182.69,"timestamp":1789167844018,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.1449033520172376},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"COAG\",,,,,undefined,":{"symbol":"COAG","floatShares":16750000,"roa":"-30.11%","roe":"-46.99%","lyrEps":-67.56131,"volumeRatio":1.1449033520172376,"shares":46705400,"dividePrice":0,"high":42.4843,"amplitude":0.087871,"preClose":39.88,"low":38.98,"week52Low":23.0001,"pbRate":"4.05","week52High":55.42,"institutionHeld":0,"latestPrice":39.4,"eps":-1.782,"divideRate":0,"volume":408085,"delay":0,"ttmEps":-1.782,"open":40.26,"prevYearClose":18,"prevWeekClose":44.41,"prevMonthClose":45.73,"prevQuarterClose":36.73,"fiveDayClose":44.37,"twentyDayClose":53.95,"sixtyDayClose":25.51},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/COAG\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-11","symbol":"COAG","fiscalQuarterEnding":"2026/06","expectedEps":-0.63,"name":null,"time":"盤前","type":"earning","dateTimestamp":1786420800000,"reportTimeType":"pre","actualEps":-0.8}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"COAG\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"COAG\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4,"buy":0.6,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6,"analysts":5,"updateTime":1781755200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/COAG\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"COAG","date":"2026-09-11","current":-22.109989,"percent":0.511111,"low":-34.170536,"twenty":-29.479949,"median":-23.509442,"eighty":-18.159648,"high":-11.042152,"avg":-23.686128,"sd":5.485186,"marketCap":1862879225},"quantilePoints":[{"date":"2026-05-01","current":-11.042152,"twenty":-11.042152,"median":-11.042152,"eighty":-11.042152,"marketCap":705737088},{"date":"2026-05-08","current":-17.79803,"twenty":-17.79803,"median":-17.407359,"eighty":-17.286354,"marketCap":1137525503},{"date":"2026-05-15","current":-19.616555,"twenty":-19.616555,"median":-17.521449,"eighty":-17.286354,"marketCap":1253752856},{"date":"2026-05-22","current":-18.185245,"twenty":-19.409118,"median":-17.853347,"eighty":-17.293269,"marketCap":1162273533},{"date":"2026-05-29","current":-19.360717,"twenty":-19.450605,"median":-18.046954,"eighty":-17.354117,"marketCap":1237401480},{"date":"2026-06-05","current":-17.56985,"twenty":-19.450605,"median":-18.185245,"eighty":-17.491025,"marketCap":1122941843},{"date":"2026-06-12","current":-18.627775,"twenty":-19.370397,"median":-18.1403,"eighty":-17.515917,"marketCap":1190556995},{"date":"2026-06-18","current":-18.288963,"twenty":-19.294337,"median":-18.002009,"eighty":-17.444006,"marketCap":1168902469},{"date":"2026-06-26","current":-18.159648,"twenty":-19.492093,"median":-18.185245,"eighty":-17.510385,"marketCap":1294673965},{"date":"2026-07-02","current":-21.291074,"twenty":-19.764526,"median":-18.302792,"eighty":-17.540809,"marketCap":1517925825},{"date":"2026-07-10","current":-24.370091,"twenty":-20.501011,"median":-18.714206,"eighty":-17.578148,"marketCap":1737441252},{"date":"2026-07-17","current":-29.172047,"twenty":-21.688778,"median":-18.837687,"eighty":-17.609955,"marketCap":2079791907},{"date":"2026-07-24","current":-30.02369,"twenty":-24.062189,"median":-19.305401,"eighty":-17.650059,"marketCap":2140508940},{"date":"2026-07-31","current":-31.09807,"twenty":-25.689482,"median":-19.512836,"eighty":-17.666654,"marketCap":2217105812},{"date":"2026-08-07","current":-34.170536,"twenty":-29.287346,"median":-19.706444,"eighty":-17.692929,"marketCap":2436154185},{"date":"2026-08-14","current":-30.277152,"twenty":-30.021629,"median":-19.996854,"eighty":-17.818774,"marketCap":2520118712},{"date":"2026-08-21","current":-27.050208,"twenty":-30.064832,"median":-20.629413,"eighty":-17.903131,"marketCap":2251524039},{"date":"2026-08-28","current":-27.774166,"twenty":-30.021629,"median":-21.296443,"eighty":-17.946001,"marketCap":2311782670},{"date":"2026-09-04","current":-24.900782,"twenty":-29.906697,"median":-22.201677,"eighty":-18.108214,"marketCap":2072616631},{"date":"2026-09-11","current":-22.38096,"twenty":-29.479949,"median":-23.509442,"eighty":-18.159648,"marketCap":1862879225}],"updateTime":1789338207514},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":1994300807,"yearFounded":2020,"address":"101 Main Street,Suite 1220,Cambridge,Massachusetts,United States","zipCode":"02142","officePhone":"(617) 553-3952","fiscalYearEnd":"12-31"},"stockCompanyDetail":{"websiteUrl":"http://www.hemab.com","stockEarnings":[{"period":"1week","weight":-0.1128},{"period":"1month","weight":-0.2633},{"period":"3month","weight":0.5773},{"period":"6month","weight":1.1889},{"period":"ytd","weight":1.1889}],"compareEarnings":[{"period":"1week","weight":-0.0077},{"period":"1month","weight":-0.0106},{"period":"3month","weight":0.0304},{"period":"6month","weight":0.154},{"period":"1year","weight":0.1622},{"period":"ytd","weight":0.1208}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Hemab Therapeutics Holdings, Inc.於2026年2月12日根據特拉華州法律註冊成立。Hemab Therapeutics是一家臨床階段的生物技術公司，致力於開發革新血液凝固障礙治療的療法，以幫助維持生命並增強人類的抵抗力。公司的使命是通過發現、開發和商業化創新療法，為全球患有嚴重出血和血栓性疾病的患者打造領先的凝血領域公司。這些疾病包括格氏血小板無力症、VII因子缺乏症、血管性血友病以及其他可能造成終身沉重負擔的異常出血性疾病。公司的主要候選藥物sutacimig (HMB-001) 是一種雙特異性抗體，目前正在進行一項針對格氏血小板無力症預防性治療的I/II期臨床試驗和一項針對VII因子缺乏症預防性治療的II期臨床試驗。","exchange":"NASDAQ","name":"Hemab Therapeutics Holdings, Inc.","nameEN":"Hemab Therapeutics Holdings, Inc."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"COAG\",market:\"US\",,,undefined,":{"directors":[{"name":"Benny Sorensen","position":"Chief Executive Officer and Director and President"},{"name":"Akshay Vaishnaw","position":"Independent Director"},{"name":"ジョンマラガノア","position":"Chair of the Board and Independent Director"},{"name":"Laura Tadvalkar","position":"Independent Director"},{"name":"Linda Bain","position":"Independent Director"}],"executives":[{"name":"Benny Sorensen","position":"Chief Executive Officer and Director and President"},{"name":"Ananthram Murthy","position":"Chief Operating Officer"},{"name":"Mads Behrndt","position":"Chief Financial Officer and General Manager"},{"name":"Catherine Madigan","position":"Chief Medical Officer"}]}}}